营养对肠道微生物群的影响:对帕金森病的影响
Joana Sobral1,2,3, Nuno Empadinhas1,2, Ana Raquel Esteves1,2
1Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra 3004-504, Portugal.
Nutrition reviews
|January 15, 2025
概括
本综述探讨了帕金森病 (PD) 的体第一亚型,重点关注肠道微生物群和营养如何影响其发展. 饮食变化和肠道微生物组调节显示了管理PD风险和进展的潜力.
科学领域:
- 神经科学是一个神经科学.
- 胃肠病学 胃肠病学
- 营养科学 营养科学
背景情况:
- 帕金森病 (PD) 涉及多巴胺能神经元退化和α-synuclein聚合.
- 存在两种PD亚型:大脑优先和身体优先,本文重点介绍后者.
- 肠道微生物群和炎症越来越多地与PD病变发生有关.
研究的目的:
- 审查肠道微生物群变异与PD之间的相关性.
- 检查营养和饮食模式对PD风险和进展的影响.
- 探索针对肠道微生物组进行PD管理的治疗策略.
主要方法:
- 关于PD,肠道微生物群和营养的最新研究的文献综述.
- 对与健康个体对比的PD患者肠道微生物组合相关的研究分析.
- 评估特定饮食 (地中海,西方,) 对肠道微生物群和PD风险的影响.
主要成果:
- 在PD患者和健康对照人群之间观察到肠道微生物群组成的显著差异.
- 饮食模式明显影响肠道微生物群,影响与PD相关的炎症标志物.
- 性饮食,地中海饮食和西方饮食对肠道微生物组合和PD风险产生不同的影响.
结论:
- 受饮食影响的肠道微生物群调节是体第一PD亚型的关键因素.
- 便移植,益生菌,益生菌和共生菌代表了潜在的治疗途径.
- 准肠道微生物群可能提供降低PD风险或延迟疾病进展的策略.
相关概念视频
Parkinson's Disease: Overview
463
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
463
Parkinson's Disease: Treatment
206
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
206
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
What is Monogastric Digestion?
70.5K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
70.5K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K


